These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 24438680)
1. IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients. Jiménez-Sousa MA; Berenguer J; Fernández-Rodríguez A; Micheloud D; Guzmán-Fulgencio M; Miralles P; Pineda-Tenor D; García-Álvarez M; López JC; Aldámiz-Echevarria T; Carrero A; Resino S J Viral Hepat; 2014 Mar; 21(3):189-97. PubMed ID: 24438680 [TBL] [Abstract][Full Text] [Related]
2. IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients. Jiménez-Sousa MA; Berenguer J; Rallón N; Guzmán-Fulgencio M; López JC; Soriano V; Fernández-Rodríguez A; Cosín J; Restrepo C; García-Álvarez M; Miralles P; Benito JM; Resino S J Viral Hepat; 2013 May; 20(5):358-66. PubMed ID: 23565619 [TBL] [Abstract][Full Text] [Related]
3. FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients. Pineda-Tenor D; Berenguer J; Jiménez-Sousa MA; García-Alvarez M; Aldámiz-Echevarria T; Carrero A; Vázquez-Morón S; García-Broncano P; Diez C; Tejerina F; Guzmán-Fulgencio M; Resino S BMC Med; 2014 Nov; 12():198. PubMed ID: 25367448 [TBL] [Abstract][Full Text] [Related]
4. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection. Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972 [TBL] [Abstract][Full Text] [Related]
5. IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus. Guzmán-Fulgencio M; Berenguer J; García-Álvarez M; Fernández-Rodríguez A; Jiménez-Sousa MA; Alvarez E; Micheloud D; López JC; Miralles P; Cosín J; Catalán P; Resino S J Infect; 2013 Feb; 66(2):170-8. PubMed ID: 23103287 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1. Ogawa E; Furusyo N; Murata M; Ikezaki H; Ihara T; Hayashi T; Toyoda K; Taniai H; Okada K; Kainuma M; Hayashi J J Hepatol; 2012 Sep; 57(3):534-40. PubMed ID: 22613000 [TBL] [Abstract][Full Text] [Related]
7. Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism. Del Campo JA; Ampuero J; Rojas L; Conde M; Rojas A; Maraver M; Millán R; García-Valdecasas M; García-Lozano JR; González-Escribano MF; Romero-Gómez M Aliment Pharmacol Ther; 2013 Jan; 37(1):74-80. PubMed ID: 23121166 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients. Fernández-Rodríguez A; Berenguer J; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarría T; Pineda-Tenor D; Diez C; de la Barrera J; Bellon JM; Briz V; Resino S Infect Genet Evol; 2015 Dec; 36():339-344. PubMed ID: 26455634 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients. Degasperi E; Valenti L; Aghemo A; De Francesco R; Rumi M; Soffredini R; Donnici L; Cheroni C; Fargion S; Zanoni V; Orsi E; Colombo M Antivir Ther; 2014; 19(8):747-53. PubMed ID: 24523350 [TBL] [Abstract][Full Text] [Related]
10. Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes. Torres-Cornejo A; Ruiz-Valderas R; Jimenez-Jimenez L; Abad-Molina C; Gutierrez-Valencia A; Viciana P; Lopez-Cortes LF J Viral Hepat; 2014 Mar; 21(3):178-88. PubMed ID: 24438679 [TBL] [Abstract][Full Text] [Related]
11. Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients. Fernández-Rodríguez A; Rallón N; Berenguer J; Jiménez-Sousa MA; Cosín J; Guzmán-Fulgencio M; Restrepo C; Lopez JC; García-Álvarez M; Miralles P; Soriano V; Benito JM; Resino S AIDS; 2013 Jan; 27(2):163-73. PubMed ID: 23135173 [TBL] [Abstract][Full Text] [Related]
12. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy. Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients. Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G; New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009 [TBL] [Abstract][Full Text] [Related]
14. Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients. Medrano LM; Rallón N; Berenguer J; Jiménez-Sousa MA; Soriano V; Aldámiz-Echevarria T; Fernández-Rodríguez A; García M; Tejerina F; Martínez I; Benito JM; Resino S J Transl Med; 2016 Sep; 14(1):257. PubMed ID: 27590274 [TBL] [Abstract][Full Text] [Related]
15. Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV-coinfected patients. Pineda-Tenor D; Berenguer J; García-Broncano P; Jiménez-Sousa MA; Fernández-Rodríguez A; Diez C; García-Álvarez M; Carrero A; Catalán P; Aldámiz-Echevarria T; Resino S Eur J Clin Invest; 2014 May; 44(5):453-62. PubMed ID: 24528335 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relationship between IL28B, IL10RB and IL28RA single-nucleotide polymorphisms and susceptibility to hepatitis C virus in Chinese Han population. Jin G; Kang H; Chen X; Dai D Infect Genet Evol; 2014 Jan; 21():8-14. PubMed ID: 24144988 [TBL] [Abstract][Full Text] [Related]
17. Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study. Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Pineda-Tenor D; Aldámiz-Echevarria T; García-Broncano P; Carrero A; García-Álvarez M; Tejerina F; Diez C; Vazquez-Morón S; Resino S J Transl Med; 2015 Jun; 13():206. PubMed ID: 26123260 [TBL] [Abstract][Full Text] [Related]
18. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C. Stättermayer AF; Rutter K; Beinhardt S; Scherzer TM; Stadlmayr A; Hofer H; Wrba F; Steindl-Munda P; Krebs M; Datz C; Trauner M; Ferenci P J Hepatol; 2012 Sep; 57(3):492-8. PubMed ID: 22634340 [TBL] [Abstract][Full Text] [Related]
19. Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population. Cui Q; Zhang YX; Su J; Chen X; Ding K; Lei N; Liu Y; Li J; Zhang Y; Yu RB Infect Genet Evol; 2011 Oct; 11(7):1682-9. PubMed ID: 21742059 [TBL] [Abstract][Full Text] [Related]
20. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C. Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]